Skip to main content

Table 3 Molecular characterization and antibiotic susceptibility of MRSA isolates from AKUHN

From: Molecular characterization of Staphylococcus aureus isolates from various healthcare institutions in Nairobi, Kenya: a cross sectional study

Isolate No.

Sample

spa type

SCCmec type

Antibiogram

R

S

I

21

Pus swab

t293

IV [2B]

TOB, CLI, ERY, LEV

LNZ, TEI, VAN, TET, TIG, MUP, RIF, SXT, MOX

 

23

Sputum

t1339

UT

SXT

TOB, MOX, ERY, CLI, VAN, TET, TIG, MUP, RIF, LEV

 

79

Pus swab

t13150a

II [2A]

ERY, CLI, LEV, MOX, TOB

TET, SXT, VAN, MUP, RIF, TIG, TEI, LNZ

 

40

Urine

t648

IV [2B]

–

ERY, CLI, TET, SXT, VAN, MUP, MOX, RIF, TIG, TOB, TEI, LNZ, LEV

 

25

Blood

t852

IV [2B]

CLI#, ERY

LNZ, MUP, MOX, RIF, SXT, TET, TEI, TIG, TOB, VAN

LEV

35

Pus swab

t345

V [5C]

RIF, SXT, TET, TOB

CLI, ERY, LNZ, MUP, MOX, TEI, TIG, VAN

LEV

13

Pus swab

t037

III [3A]

CLI, ERY, SXT, TOB

LNZ, MUP, MOX, RIF, TET, TEI, TIG, VAN

LEV

11

Pus swab

t037

III [3A]

CLI#, SXT, TET, TOB

ERY, LNZ, MUP, MOX, RIF, TEI, TIG, VAN

LEV

89

Pus swab

t13149a

IV [2B]

TOB, SXT, ERY

CLI, LNZ, TEI, VAN, TET, TIG, MUP, RIF, LEV, MOX

 

75

Blood

t9622

IV [2B]

–

ERY, CLI, TET, SXT, VAN, MUP, MOX, RIF, TIG, TOB, TEI, LNZ

LEV

83

Sputum

t005

IV [2B]

TOB, ERY, CLI#

MOX, LNZ, TEI, VAN, TET, TIG, MUP, RIF, SXT

LEV

28

Nasal swab

t005

IV [2B]

ERY, CLI#, TOB, LEV

TET, SXT, VAN, LNZ, TEI, MUP, MOX, RIF, TIG

 

81

Ear swab

t1476

V [5C]

ERY, CLI#, TET, SXT, LEV

VAN, MUP, MOX, RIF, TIG, TEI, LNZ

TOB

6

Nasal swab

t091

V [5C]

SXT, TET, TOB

CLI, ERY, LNZ, MUP, MOX, RIF, TEI, TIG, VAN

LEV

29

Pus swab

t2029

IV [2B]

CLI, ERY, RIF, SXT, TET, TOB

LNZ, MUP, MOX, TEI, TIG, VAN

LEV

1

Blood

t037

III [3A]

ERY, CLI#, TET, SXT, RIF, TOB, LEV

VAN, MUP, MOX, TIG, TEI, LNZ

 
  1. R resistant, S susceptible, I intermediate, ERY erythromycin, CLI clindamycin, CLI # inducible clindamycin resistance, TET tetracycline, SXT trimethoprim/sulfamethoxazole, VAN vancomycin, GENT gentamicin, MUP mupirocin, MOX moxifloxacin, RIF rifampicin, TIG tigecycline, TOB tobramycin, TEI teicoplanin, LNZ linezolid, LEV levofloxacin
  2. aNew spa type